V. Rohmer

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients

H. Valdes Socin, P. Chanson, B. Delemer et al. · European Journal of Endocrinology · 2003 · 281 citations · Full text

Medicine, Endocrinology, Pathology +13

Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves’ Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study

J.-L. Wémeau, Philippe Caron, Albert Beckers et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.

Michel Krempf, V. Rohmer, Michel Farnier et al. · PubMed · 2000 · 28 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo.

M. Duet, Christiane Ajzenberg, S. Benelhadj et al. · PubMed · 1999 · 24 citations

Medicine, Endocrinology, Nuclear Medicine +17